Skip to main content

Houlihan Capital

SPACs – Proposed New Rules by the SEC

The SEC recently proposed new rules and amendments intended to enhance investor protections in initial public offerings by special purpose acquisition companies (“SPACs”) and in subsequent business combination transactions between SPACs and private operating companies. If adopted, the rules would impact SPACs in a variety of important ways. Below we summarize and comment upon the […]

Houlihan Capital Advised on the Recapitalization of DocMJ by Chatham Capital

Houlihan Capital’s Investment Banking Group is pleased to announce the following transaction: October 2021 Recapitalization of DocMJ Debt & Equity Provided by Chatham Capital Sector: Ancillary Services – Cannabis Houlihan Capital acted as the exclusive financial advisor to DocMJ, the leading group of medical marijuana doctors in the state of Florida, on its recapitalization through […]

Quarterly Industry Report Updates are Available for Q1 2022

Houlihan Capital provides Quarterly Updates on the following industries as of March 31, 2022. Information includes valuation metrics, performance data and M&A activity. Click on the following links below to access reports for the following industries: Aerospace, Defense & Government Asset Management Banking Building Products Business Services Cannabis Chemicals Consumer Products Internet Retail Media and […]

Houlihan Capital Advised on the Sale of Northside Emergency Pet Clinics to PetVet Care Centers

March 2022 Northside Emergency Pet Clinics Sale to PetVet Care Centers Sector: Veterinary Medicine Houlihan Capital acted as exclusive financial advisor on the sale of Northside Emergency Pet Clinics (“NEPC”), a provider of emergency veterinary medicine, to Connecticut-based PetVet Care Centers (“PetVet”), a portfolio company of KKR. With locations in Westminster and Boulder, CO, Northside […]